Silver Book Fact

Annual direct cost of Afib

Fact image

Average annual cost comparison between patients with and without atrial fibrillation

Wu, Eric Q, Howard G Birnbaum, Milena Mareva, Edward Tuttle, Adam R Castor, Warren Jackman, and Jeremy Ruskin. Economic Burden and Co-Morbidities of Atrial Fibrillation in a Privately Insured Population. Curr Med Res Opin. 2005; 21(10): 1693-9. http://informahealthcare.com/doi/abs/10.1185/030079905X65475

Reference

Title
Economic Burden and Co-Morbidities of Atrial Fibrillation in a Privately Insured Population
Publication
Curr Med Res Opin
Publication Date
2005
Authors
Wu, Eric Q, Howard G Birnbaum, Milena Mareva, Edward Tuttle, Adam R Castor, Warren Jackman, and Jeremy Ruskin
Volume & Issue
Volume 21, Issue 10
Pages
1693-9
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Atrial fibrillation prevalence projection, 2050
    Atrial fibrillation prevalence is projected to rise to between 5.6 and 12.1 million in 2050.  
  • Risk of ischemic stroke in AFib patients
    The risk of ischemic stroke in nonvalvular atrial fibrillation patients is 2 to 7 times (200% to 700%) greater than in those without the disease.  
  • Average length of stay for major bleeding complications
    The average length of stay for major bleeding complications is six days.  
  • Medical service utilization in AFib
    Medical service utilization in persons with and without atrial fibrillation  
  • Lifetime risk of developing atrial fibrillation for men and women
    The lifetime risk of developing atrial fibrillation is around 1 in 4 for both men and women age 40 and older.